Philip Wastall
About Philip Wastall
Philip Wastall is an Associate Director and Sr Clinical Scientist at Bristol-Myers Squibb in Princeton, New Jersey, with over 20 years of experience in Clinical Operations.
Current Position at Bristol-Myers Squibb
Philip Wastall currently holds the position of Associate Director at Bristol-Myers Squibb. Additionally, he serves as a Senior Clinical Scientist at the company, contributing his expertise in clinical operations. He is based in Princeton, New Jersey and has been with Bristol-Myers Squibb since January 2006. In his role, he focuses on managing clinical trials and protocols, particularly within the oncology Phase III scope.
Previous Experience at Pfizer
Before joining Bristol-Myers Squibb, Philip Wastall worked at Pfizer as a Clinical Scientist from 2002 to 2006. During his four years at Pfizer, he was involved in various clinical operations and trials. This experience provided him with a solid foundation in clinical research and trial management, which he later brought to his roles at Bristol-Myers Squibb.
Educational Background
Philip Wastall studied Biochemistry at the University of Bath, earning a Bachelor of Science (BS) degree. He attended the university from 1982 to 1986. This academic background in biochemistry has been instrumental in his career in clinical research and operations.
Clinical Operations Experience
With 20 years of experience in clinical operations, Philip Wastall has worked across Phase I, II, and III trials. His extensive background includes managing and overseeing clinical trials, ensuring compliance, and contributing to protocol development. His roles have spanned various phases of clinical research, providing him with a comprehensive understanding of the field.
Role as Lead Protocol Manager in Oncology
In his current position, Philip Wastall serves as a Lead Protocol Manager specializing in Phase III oncology trials. His responsibilities include overseeing the development and execution of clinical trial protocols, ensuring that all regulatory and compliance standards are met, and coordinating with various stakeholders to facilitate smooth and effective trial operations.